NCT02588807View on ClinicalTrials.gov

Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

January 1, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

May 31, 2022

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

Spirit1

Spirit 1 is a combination of phospholipids and anti-oxidant medicinal plants

Trial Locations (1)

Unknown

Hacarmel Hospital, Haifa

Sponsors

Collaborators (1)

Carmel Medical Center

All Listed Sponsors

collaborator

Carmel Medical Center

OTHER

lead

Herb Spirit

INDUSTRY

NCT02588807 - Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter